Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Prospective, Multicenter Study of the Safety and Efficacy of "UniLine" Epoxy-treated Prosthesis Made From Xenopericardium in the Treatment of Isolated Aortic and Mitral Valve Diseases

NCT06025149 is registered in ClinicalTrials.gov with Closed Joint-Stock Company NeoCor as lead sponsor.

NCT NCT06025149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06025149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Prospective, Multicenter Study of the Safety and Efficacy of "UniLine" Epoxy-treated Prosthesis Made From Xenopericardium in the Treatment of Isolated Aortic and Mitral Valve Diseases
Lead sponsor
Closed Joint-Stock Company NeoCor
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2018
Completion date
January 31, 2035
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve disease, mitral valve disease